115379 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39026)
  2. GSK Faculty (22463)
  3. Solid Tumor Oncology Division (22051)
  4. Surgery (21243)
  5. Sloan Kettering Institute Faculty (16084)
  6. Survivorship Research (15761)
  7. Center for Hematologic Malignancies (13261)
  8. Hematologic Malignancies, Division of (13086)
  9. Sloan Kettering Institute Postdocs (12932)
  10. Department of Pathology and Laboratory Medicine (12602)
Formats
  1. Journal Article (66748)
  2. Meeting Abstract (33628)
  3. Book Section (5027)
  4. Review (3743)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39026)
  2. GSK Faculty (22463)
  3. Solid Tumor Oncology Division (22051)
  4. Surgery (21243)
  5. Sloan Kettering Institute Faculty (16084)
  6. Survivorship Research (15761)

More Groups

People
  1. Marc Ladanyi (1326)
  2. Robert Motzer (1243)
  3. Victor Reuter (1224)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1049)

More People

Years
  1. 2025 (1983)
  2. 2024 (5385)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115379)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Preliminary results from FLAGSHP-1: A phase 1 study of ERAS-601 as a monotherapy or in combination with cetuximab in patients (pts) previously treated for advanced chordoma
    Meeting Abstract

    Gounder, M. M.; Rosen, E.; Parikh, A. R.; Conley, A. P.; Hong, D. S.; Sheth, S.; Mai, N.; Sgroe, E.; Mitchell, R.; Picard, R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase I/II first-in-human study to evaluate the safety and efficacy of tissue factor-ADC MRG004A in patients with solid tumors
    Meeting Abstract

    Park, W.; Zhang, J.; Dayyani, F.; Shan, J.; Liu, R.; Guo, R.; O'Reilly, E. M.; Liu, Z.; Gao, S.; Wu, X.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Efficacy of treatment with traditional Chinese patent medicine (Fufang E'jiao Syrup) for cancer-related fatigue in patients with advanced cancer: A randomized, double-blinded, placebo-controlled, multicenter trial
    Meeting Abstract

    Gu, S. S.; Xu, Y.; Mao, J. J.; Sun, L.; Cui, N.; Wang, F.; Dong, J.; Guo, X.; Fu, L.; Wang, J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Safety and efficacy of osimertinib plus consolidative stereotactic ablative radiation (SABR) in advanced EGFR mutant non-small cell lung cancer (NSCLC): Results from a multi-center phase II trial
    Meeting Abstract

    Rashdan, S.; Sampath, S.; Iyengar, P.; Dowell, J.; Ahn, C.; Westover, K. D.; Zhang, Y.; Cole, S.; Massarelli, E.; Amini, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Real-world treatment patterns and outcomes in patients with myelofibrosis treated with pacritinib in the United States
    Meeting Abstract

    Marrone, M.; Geller, R.; Oladapo, A.; Suthar, P.; Vasudevan, A.; Vredenburg, M.; Zeng, J.; Rampal, R.; Mascarenhas, J.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Improving access to palliative care to mitigate multi-dimensional breast cancer suffering
    Meeting Abstract

    Knaul, F. M.; Rosa, W. E.; Radbruch, L.; Jiang, X. X.; Vargas, V.; Bhadelia, A.; Arreola-Ornelas, H.; Coppola, M.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Multidimensional analysis of B7 homolog 3 (B7-H3) RNA expression in small-cell lung cancer (SCLC) molecular subtypes
    Meeting Abstract

    Gay, C. M.; Owonikoko, T. K.; Byers, L. A.; Choudhury, N. J.; Ahmed, S.; Cain, Z.; Qian, X. Z.; Brentnall, M.; Heeke, S.; Poi, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Impact of trial eligibility criteria on enrollment to KRAS(G12C) inhibitor trials in patients with non-small cell lung cancer
    Meeting Abstract

    May, M. S.; Wooster, M.; May, B.; Shu, C. A.; Henick, B. S.; Stoopler, M.; Smith-Marrone, S.; Saqi, A.; Mansukhani, M. M.; Riely, G. J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Preliminary results of the Lung Cancer Mutation Consortium LCMC4 evaluation of actionable drivers in early stage lung cancer (LEADER) screening trial
    Meeting Abstract

    Chaft, J. E.; Swanson, S.; Lee, J. M.; Lin, J.; Tsukada, H.; Li, T.; Ripley, R. T.; Kaifi, J. T.; Baik, C. S.; Bunn, P. A. Jr.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Enhancing thoracic oncology in Armenia: Impact of the implementation of an expert-guided virtual multidisciplinary tumor board
    Meeting Abstract

    Zohrabyan, D.; Karapetyan, N.; Tamamyan, G.; Safaryan, L.; Bardakhchyan, S.; Karamyan, S.; Ghayamyan, M.; Khachatryan, M.; Danielyan, S.; Rushanyan, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save